Clinical Trials

The LupusQoL has been successfully used in numerous studies with positive results. Some of the clinical trials that have used the LupusQoL include:

• A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
• A Study of LY2127399 in Patients With Systemic Lupus Erythematosus
• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (EMBODY 1)
• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) (EMBODY 2)
• Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus (EMBODY 4)
• Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus